Curriculum
Course Description:
Differing levels of excipients within inhalation products may have a significant impact on product performance and, from a scientific and regulatory perspective, will need to be evaluated on a case-by-case basis.
Featuring Kimberly Witzmann, M.D., U.S. FDA
Access Duration:Access to this course expires 60 days from the date of registration or until you mark the course ‘Complete’ – whichever occurs first.